Compare DKS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DKS | SNN |
|---|---|---|
| Founded | 1948 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Other Specialty Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 14.3B |
| IPO Year | 2002 | N/A |
| Metric | DKS | SNN |
|---|---|---|
| Price | $230.50 | $33.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 2 |
| Target Price | ★ $247.00 | $36.25 |
| AVG Volume (30 Days) | ★ 1.1M | 742.2K |
| Earning Date | 05-27-2026 | 03-16-2026 |
| Dividend Yield | 2.17% | ★ 2.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.97 | N/A |
| Revenue | ★ $17,215,120,000.00 | N/A |
| Revenue This Year | $30.02 | $8.58 |
| Revenue Next Year | $3.69 | $5.60 |
| P/E Ratio | ★ $23.18 | $64.97 |
| Revenue Growth | ★ 28.06 | N/A |
| 52 Week Low | $167.03 | $26.33 |
| 52 Week High | $237.31 | $38.79 |
| Indicator | DKS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 76.30 | 48.02 |
| Support Level | $214.51 | $33.10 |
| Resistance Level | $234.83 | $33.89 |
| Average True Range (ATR) | 6.95 | 0.56 |
| MACD | 3.26 | 0.19 |
| Stochastic Oscillator | 95.54 | 52.31 |
Dick's Sporting Goods is a retailer that offers sports and outdoor apparel, footwear, and equipment online and in physical stores. The company's legacy business includes more than 700 stores under its own name, more than 110 Golf Galaxy golf specialty stores, and about 50 outlet stores. In September 2025, Dick's acquired multinational retailer Foot Locker. With this move, Dick's added about 2,600 stores under the Foot Locker, Kids Foot Locker, Champs Sports, atmos, and WSS nameplates in North America, the Asia-Pacific, and EMEA—Europe, the Middle East, and Africa. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.